AVE 16.7% 0.3¢ avecho biotechnology limited

the dream machine, page-15

  1. 564 Posts.
    lightbulb Created with Sketch. 1
    Clearly the day trading children have found a new toy called OBJ today.

    A lot of numbers and assertions being thrown around here without much clarity around them.

    $2 million in cosmaceutical sales, what does this actually mean for POH? Is that sales at the retail level? What percentage of $2 million actually accrues to POH? I think expectations of significant revenue coming from this source is overblown at this early stage.

    Oxycodone has a $US 3.5 billion market, this number is meaningless except to say that it is large. POH are not selling the drug, they are selling a mechanism for delivery and targetting the largest segment of that market, chronic pain sufferers. Again what is POH`s potential revenues if say they penetrated 25% of the market? Would it be measured in millions, tens of millions or hundreds of millions?

    This company would need to make a profit after tax of $75million just to produce $0.10 in earnings. How many years is POH away from that? 3 years, 5 years? Still a lot of wishful thinking here and not much reality.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.226K 1.116M

Buyers (Bids)

No. Vol. Price($)
52 92468918 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 76402411 25
View Market Depth
Last trade - 12.50pm 06/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.